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Abstract.  Leukocyte interactions  with vascular en- 
dothelium at sites of inflammation can be dynamically 
regulated by activation-dependent adhesion molecules. 
Current models, primarily based on studies with poly- 
morphonuclear leukocytes, suggest the involvement of 
multiple members of the selectin,  integrin,  and immu- 
noglobulin gene families,  sequentially,  in the process 
of initial  attachment  (rolling),  stable adhesion (arrest), 
spreading and ultimate diapedesis. In the current 
study, IL-4-activated human umbilical vein en- 
dothelium,  which selectively expresses VCAM-1  and 
an L-selectin ligand but not E-selectin,  and appropri- 
ate function blocking monoclonal antibodies, were 
used to study monocyte-endothelial interactions in an 
in vitro model that mimics microcirculatory flow con- 
ditions.  In this system, L-selectin mediates monocyte 
rolling and also facilitates ouBl-integdn-dependent ar- 
rest, whereas/~-integrins  are required for spreading of 
firmly attached monocytes on the endothelial cell sur- 
face but not their arrest.  These findings provide the 
first in vitro evidence for human monocyte rolling on 
cytokine-activated endothelium,  and suggest a  sequen- 
tial requirement for both/~1- and/~2-integfin-dependent 
adhesive mechanisms in monocyte-endothelial interac- 
tions. 
p 
ERIPHERAL blood monocytes interact with the vascu- 
lar endothelial  lining as an initial step in a wide range 
of pathological processes including acute and chronic 
inflanunation,  immune reactions,  and atherosclerosis (12, 
13, 45). As a consequence of their  transendothelial  migra- 
tion, monocytes are recruited into tissues, organs and body 
cavities,  undergo maturation to macrophages,  and partici- 
pate in defending  the host against  invading pathogens  and 
regulating  the behavior of vascular and non-vascular  cells 
through the secretion of cytokines and other chemical medi- 
ators. 
Early in vitro studies of monocyte adhesion to cultured en- 
dothelial  cells were typically performed under static condi- 
tions  and  indicated  that basal adhesion of purified  blood 
monocytes was relatively high (2, 5, 6, 9, 15, 20, 21, 38, 40) 
compared with neutrophils  or lymphocytes (9, 34, 35, 38, 
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63). Activation  of the endothelium with TNF-o~, IL-1, and 
LPS (6,  20),  resulted in a  2-5-fold increase in monocyte 
adhesion.  This enhanced monocyte adhesion reflects the in- 
duction of multiple  adhesion  molecules on the endothelial 
surface including  E-selectin,  which  interacts  with  sialyl- 
Lewis  x and  similar  carbohydrate  ligands;  Vascular  Cell 
Adhesion Molecule-1 (VCAM-1),  ~  which interacts with Ct~l- 
integrins;  and Intercellular  Adhesion Molecule-1 (ICAM-1), 
which interacts with/~2-integrins  (CDlla/CD18 and CDllb/ 
CD18) (4, 9, 20, 57). That multiple molecules are induced 
suggests redundancy  or overlap in their function.  However, 
recent studies performed in vivo, or in vitro under defined 
flow conditions,  have further clarified the conceptual frame- 
work of leukocyte-endothelial  adhesion by revealing that var- 
ious receptor-ligand  pairs can function in a sequential man- 
ner to mediate these adhesive interactions  (7, 62).  In the 
molecular models that have been proposed, the initial attach- 
ment of the blood leukocyte is mediated,  in part, by L-selec- 
1. Abbreviations used in this paper: HEV, high endothelial venules; HSA, 
human serum albumin; HUVEC, human umbilical vein endothelial cell; 
ICAMd, Intercellular Adhesion Molecule-l; IL-4, intedeukin-4; VCAM-1, 
Vascular Cell Adhesion Molecule-1. 
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/32-integrins. However, these models are primarily based on 
observations with polymorphonuclear leukocytes (in partic- 
ular neutrophils),  and the extent to which monocytes con- 
form to this paradigm remains untested.  In addition to ex- 
pressing both L-selectin and/~2-integrins,  blood monocytes 
also express multiple/~-integrins  (53),  of which the a4/3~ 
molecule has been shown to interact with both matrix pro- 
teins and the endothelial  expressed molecule, VCAM-1 (16, 
58).  Thus,  although  o~,  interacting  with its  endothelial 
ligand VCAM-1, has been implicated  in monocyte recruit- 
ment during early atherosclerotic  plaque formation in vivo 
(11-13),  and  in  monocyte adhesion to  activated  endothe- 
lial cells in vitro (8, 9, 20, 41, 55), its potential role in mono- 
cyte adhesion under defined  flow conditions has yet to be 
examined. 
Interleukin-4  (IL-4), originally described as a costimula- 
tory factor necessary for B-cell proliferation  (23,  66), has 
been shown to exert pleiotropic  effects on several blood cell 
types in vitro  including  B cells,  activated  T cells,  thymo- 
cytes,  mast cells,  and monocytes/macrophages (for review 
see 66). Recent in vitro studies under static conditions have 
demonstrated that IL-4 also can stimulate cultured vascular 
endothelium  to  increase  its  adhesiveness  for  peripheral 
blood lymphocytes (36, 61), eosinophils and basophils, but 
not neutrophils (49), and to induce the synthesis of monocyte 
chemotactic peptide-1 (MCP-1) (42, 44), a monocyte-directed 
chemoattractant  (37,  43,  67).  In contrast  to the cytokines 
IL-1 and TNE and LPS, which induce E-selectin, P-selectin, 
ICAM-1, VCAM-1 and a ligand for L-selectin (4, 48, 56, 65), 
IL-4 selectively induces surface expression of VCAM-1, does 
not alter ICAM-1 expression and does not induce E-selectin 
expression (36,  49, 60, 61). 
The aim of the present study was to examine in detail the 
cellular processes and molecular mechanisms of monocyte- 
endothelial adhesion using an in vitro flow model (50). This 
system allows direct microscopic examination of monocyte- 
endothelial  interactions,  live-time, under a range of defined 
laminar  flow  conditions  that  mimic  blood  flow  in  post- 
capillary  venules (22). We used IL-4 activation of cultured 
human  umbilical  vein  endothelial  cell  (HUVEC)  which 
selectively induces both VCAM-1 and an L-selectin ligand 
but not E-selectin (36, 49, 60, 61), and appropriate function- 
blocking mAb, to investigate the molecular mechanisms in- 
volved in  monocyte-endothelial adhesive  interactions  un- 
der  defined  flow conditions.  The results  demonstrate  that 
L-selectin mediates monocyte rolling  and facilitates  arrest 
through  t~,/3t-integrins interacting  with  VCAM-1. In con- 
trast/~2-integrins  were required for the spreading of firmly 
attached monocytes on the endothelial  surface,  but not for 
their arrest. These data thus suggest a complex, sequential, 
molecular model for monocyte-endothelial adhesive interac- 
tions under defined flow conditions. 
Materials and Methods 
Materials 
EDTA and Hepes were purchased from Sigma Chem. Co. (St. Louis, MO). 
Human serum albumin (HSA, Buminate 25 %, sterile and nonpyrogenic so- 
lution) was obtained from Baxter Healthcare Corp. (Glendale,  CA). HBSS 
with or without Ca  2+ and Mg  2+, DPBS, M199, DMEM for hybridoma cul- 
ture and RPMII640 with 25 mM Hepes were purchased from Whittaker 
Bioproducts (Walkersville, MD). rhIL-4 (produced in E. coil) was obtained 
from Genzyme,  Inc. (Cambridge,  MA). The working solution of IL-4 that 
gave the maximal response (10-50 ng/ml; three different lots) contained less 
than 10 pg/ml of endotoxin as determined in a semi-quantitative E-toxate 
assay kit (Sigma Chem. Co). 
Monoclonal Antibodies 
The anti-E-selectin (H18/7, IgCr~ (5), anti-ICAM-1  (HuS/3,  IgG  0  (35), 
and anti-HLA-A,B  (W6/32,  IgG2.)  (5,  35) mAb were used as purified 
F(ab')2  fragments  at  saturating  concentration (25  pg/ml)  in  adhesion 
blocking studies and as hyhridoma culture supernatant fluid for surface im- 
munofluorescence  assays. Murine mAb directed against distinct epitopes of 
L-selectin (anti-LAMl, all of the IgGi isotype)  were used as purified IgG 
at 10/~g/rnl (54-56). The anti-VC_.AM-1 l-nAb El/6 (IgG0 (41) and Hu 8/4 
(58) were used as purified IgG (20/xg/ntl) and F(ab')2 (20 t~g/ml), respec- 
tively,  mAb TS1/18.1 (1gGl) (Amer.  Type Culture Collection,  Rockviile, 
MD,  clone lib 203) recognizes the fl2-integrins  (CDll/CDIS) and was 
used as purified IgG (50 pg/rnl) (47). Murine mAb directed to CDI4 (63D3) 
was obtained from ATCC (clone 44-HB) and used as diluted ascites fluid 
(1:300)  or purified  IgG in indirect immunofluorescence  assays.  Murine 
mAb 19H8 (IgGl; 1:300 dilution of ascites)  recognizes  a4fll and was the 
gift of Dr. Brad McIntyre, Baylor College of Medicine, Houston, TX (49). 
Rat monoclonal antibody MAB13  (IgG2,)  (1)  recognizes  human ill- 
integrins (CD29) and was  used as  purified  IgG  (25  btg/mi).  Rat mAb 
M18/2.a.8  (IgG~O recognizes murine but not human CDI8 (ATCC, clone 
TIB-218)  and was used as a  control isotype matched non-binding mAb 
(purified  IgG) in adhesion assays. 
Cell Culture 
HUVEC were isolated from two to five umbilical cord veins, pooled, and 
established as primary cultures in M199 containing 20% FCS (Hyclone 
Labs., Urem, UT) (34,  35).  Primary HUVEC cultures were serially pas- 
saged (1:3 split ratio) and maintained in M199 containing 10% FCS,  en- 
dothelial cell growth  factor (50 /~g/ml, Biomedical  Technologies,  Inc., 
Stoughton, MA), porcine intestinal heparin (50/~g/ml, Sigma Chem. Co., 
St. Louis,  MO), and antibiotics.  For experimental use,  HUVEC (passage 
1-2) were plated on 25  x  75 mm permanox plastic tissue culture slides 
(American Bioanalytical,  Nafick,  MA) or glass microscope slides (Fisher 
Scientific, Medford,  MA) coated with human flbronectin (2/~g/cm2;  Col- 
laborative Research, Bedford, MA) and grown within a 2-cm diam circle 
delineated by a ring of 12 M polysiloxane.  For adhesion studies in the flow 
plate  apparatus,  25-ram  glass  coverslips  (No.  1  thickness,  Thomas 
Scientific, Swedesboro, NJ) were immersed in 1 N NaOH for 1 h and exten- 
sively rinsed in distilled H20. The coverslips were dipped in absolute etha- 
nol, flamed in a bunsen burner to evaporate the ethanol and coated with 2 
/~g/cm  2  human  fibronectin.  HUVEC  (subculture  1-2)  were  plated  at 
confluent  density and incubated for 24 h before cytokine treatment. For sur- 
face immunnfluorescence  studies,  HUVEC were plated on 0.1% gelatin- 
coated  or  fibronoctin-coated  plastic wells  of 96  well  microtiter plates 
(Costar Corp., Cambridge, MA). Experiments were initiated once HUVEC 
were confluent (r~24 h). 
Leukocyte Isolation and Culture 
Human monocytes were isolated from anticoagulated  whole blood or from 
platelet pheresis residues by centrifugation on Ficoll-Hypaque  density gra- 
diem centrifugation at 15°C (LSM, Organon Teknika,  Durham, NC) fol- 
lowed by counterflow  centrifugation elutriation in a Beckman/2-21 M/E 
centrifuge using a JE-6 elutriation rotor and a 6-ml Sanderson chamber 
(Beckman Instruments, Pale Alto, CA). The method developed by Doherty 
et al. (14,  15) was used with the following modifications.  The elutriation 
buffer was DPBS supplemented with 3 mM EDTA and 0.25%  HSA.  The 
elutriator rotor and harness was assembled, sterilized with chlorox bleach, 
and flushed  with 1,000 ml of sterile DPBS.  The mononuclear cell frac- 
tion isolated by Ficoll-Hypaque  density gradient (3  -  8  x  l0  s cells) was 
loaded at 14 ml/min onto the elutriator centrifuge rotor head (2,500 +  10 
rpm at 10°C) and fractions of elutriated cells were collected  at increasing 
flow rates (14,  15). Monocytes eluted at 21.5 rail/rain. Monocyte suspen- 
sions were 89 + 4% (N =  17) pure with 8% lymphocyte,  <2% granulocyte 
and essentially  no platelet contamination as determined by light scatter 
(FACSCAN, Bocton Dickinson, Mountain View, CA) and cell surface anti- 
gen analysis with mAb directed to CD14. Monocytes were resuspended  in 
cold DPBS containing 0.75 mM Ca  2+ and 0.75 mM Mg  2+ and 0.2%  HSA. 
All buffers and reagents contained <10 pg/ml of endotoxin. 
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1640 with 25 mM Hepes containing 10% FCS, 1 mM L-glutamine and anti- 
biotics. U937 cells stably expressing human L-selectin were prepared by 
electroporation of cells with 40 #g of the pLAM-1 eDNA (59) in the pZIP- 
neo SV(x) vector. Transfectants were selected in medium containing 0.5 
mg/ml C,-418. 
Murine  L-cells were obtained from ATCC  and were maintained in 
DMEM with 10% FCS. L-cells stably expressing the 7-domain form of hu- 
man VCAM-1 were prepared by electroporation of cells with 20 #g of the 
VCAM-1 cDNA in a modified SRc~ vector. Transfectants were selected in 
DMEM-10% FCS containing 0.5 mg/ml G418. In preliminary adhesion ex- 
periments, L-Cell-VCAM-1  monolayers were uniformly positive by flow 
cytometry with anti-VCAM-1 mAb (El/6) and supported significant VCAM- 
1-dependent monocyte attachment under rotation conditions (media, 267 + 
42 monocytes/20× power field; El/6 mAb 56  +  19, triplicate wells). 
Endothelial-Leukocyte Attachment Assay 
Attachment assays were carried out under rotation (64 rpm) as previously 
described in detail (55, 56). Briefly, confluent HUVEC were stimulated for 
24 h (or as otherwise stated) with culture media containing an optimal con- 
centration of rhIL-4 (Genzyme, Inc., Boston, MA). Before assay, HUVEC 
monolayers were washed three times with assay media (RPMI-1640 con- 
taining 5% FCS and 1 raM L-glutamine) and incubated at 37°C with assay 
media  alone  or  media  containing  saturating  concentrations of various 
HUVEC-directed or leukocyte-directed mAb for 30 rain. In parallel, leuko- 
cytes (4 x  10  ~) were centrifuged (300 g, 5 rain at 4°C) and suspended in 
cold assay buffer (100  #l, total volume) containing leukocyte-directed or 
HUVEC-directed mAb or both for 20 min. Leukocyte suspensions were 
added to  HUVEC  monolayers that were rotating at  64  rpm under hu- 
midified conditions at 37°C. After incubation for 8 min, the medium was 
gently removed and the slides were placed vertically in ice-cold fixative (1% 
glutaraldnhyde (Sigma) in PBS, pH 7.4) and stored overnight at 4°C. The 
number of  adherent monocytes was determined by counting 6 different fields 
using an ocular grid and 20x  objective (0.16 mm  2 per field). Fields for 
counting adherent leukocytes were located at half radius distances from the 
center of the monolayers. The percent inhibition was calculated as previ- 
ously described (55). 
Endothelial-Leukocyte Interactions in a Parallel Plate 
Flow Chamber 
Apparatus Design.  The parallel-plate flow chamber used in this study has 
been described in detail (50). Briefly, the chamber is composed of  two stain- 
less steel plates separated by a silastic gasket (250 t~m thickness, Dow Com- 
ing). The flow channel is formed by removal of a 5.0 × 50.0 mm rectangular 
section from the silastic gasket. Defined levels of flow are applied to the 
HUVEC monolayer by perfusing media (DPBS containing 0.75 mM Ca  2+ 
and Mg  2+ and 0.2% HSA) through the channel using a syringe pump (Har- 
vard Apparatus, Natick, MA). A copper heating plate with two electrical 
heating cartridges (SC12-1, Hotwatt, Danvers, MA) was mounted on the top 
of the chamber to maintain temperature at 37°C. The channel flow can be 
approximated as two-dimensional fully developed laminar flow with a sim- 
ple parabolic velocity profile since the channel height is a linear function 
of the volume flow rate through the channel. Various wall shear stress levels 
were achieved with the following flow rates: 0.4 dynes/cm  2, 0.2 ml/min; 
0.8 dyocs/cm  2, 0.4 ml/min;  1.8 dynes/cm  2, 0.85  ml/min; 4.4 dynes/cm  2, 
2.2 ml/min. 
Experimental  Application.  Confluent endothelial monolayers on glass 
coverslips were incubated with culture media containing rhIL-4 or culture 
media alone for 24 h. Before assay,  HUVEC monofayers were incubated 
with culture media containing various mAb or culture media alone for 30 
min at 370C, and then carefully positioned in a circular recess in the bottom 
plate of the chamber where a portion (5.0  x  25.0  ram) of the monolayer 
was exposed to flow. Care was taken to eliminate air bubbles in the channel 
during loading of the coverslip and assembly of the flow chamber as previ- 
ously detailed (50).  The flow apparatus with a  HUVEC monolayer was 
mounted on an inverted microscope (Nikon Diaphot-TMD, Melville, NY) 
equipped with 10×  and 40×  phase contrast objectives. A circular glass 
window in the top plate allows direct live time microscopic examination of 
the monolayer exposed to flow. The monolayer was perfused for 5-10 rain 
with perfusion media to verify that the monolayer was confluent and intact. 
Concomitantly, monocytes or U937 cells (1.2  x  107) were incubated with 
various mAb for 10 min at 4°C and diluted with perfusion media to 106 
cells/ml. The mAb concentration was adjusted to saturating levels in the 
perfusion buffer and leukocytes were perfused through the chamber at con- 
trolled flow rates. The entire period of perfusion was recorded on videotape 
using a video camera and a video recorder (Panasonic model AG-6750A) 
equipped with a time-date generator with a millisecond clock (Panasonic 
model WJ-810). Leukocyte adhesion was determined after 10 rain of perfu- 
sion by analysis of 12-15 high power (40×) fields from videotape. Leuko- 
cytes were considered to be adherent after 30 s of stable contact with the 
monolayer and usually were well spread on the luminal surface of the en- 
dothelium. Since ,,o8% of the cell suspension was lymphocytes, we deter- 
mined whether lymphocytes attached to IL-4 activated HUVEC under flow 
at 18 dynes/era  2. Lymphocyte adhesion was very low (3 +  2 lymphocytes 
(98%  pure) per 40×  field ('075 cells/ram  2) whereas monocyte adhesion 
was quite large (35-50 monocytes/field (750-1,000/mm2).  Thus, based on 
these data and the fact that contaminating lymphocytes make up 8 % of the 
monocyte suspension used in our studies, the overall contribution of lym- 
phocytes would be small. For calculation of monocyte-endothalial interac- 
tions, rolling monocytes were not considered as "adherent: The velocities 
of 50-70 consecutive leukocytes in the field of focus flowing past a 2,500 
#m  2 area were determined at multiple time points during perfusion by 
measurement of time required to travel 20 #m in multiple frames of video- 
tape. The 2,500 #m  2 area for view on the video screen is formed by a solid 
mask placed over the entire video screen with an area removed from the 
center to expose a portion of the microscopic field (50 x  50 #m). Distances 
were calibrated for each experiment using a Neubauer cell counting cham- 
ber grid or stage micrometer. Leukocytes rolling on the endothelium were 
easily visualized since they travel more slowly ('°80 t~m/s) than free-flowing 
cells. 
Immunofluorescence  Assays.  Indirect immunofluorescence assays for 
L-selectin, CDll/CD18 and CD14 surface expression on leukocytes were 
performed as previously reported (34) using mAb LAM1-3,  TS1/18 and 
63D3,  respectively, and a two step detection protocol using FITC-conju- 
gated goat anti-mouse F(ab')2 (Caltag, S. San Francisco, CA). The fluo- 
rescence of 10,000 cells was measured on a FACScan (Becton Dickinson) 
and the data are presented as mean channel fluorescence (4 decade log 
scale) vs cell number. 
Statistics.  The adhesion data was collected using ANOVA and Student's 
two sample t test was used to calculate statistical significance. ANOVA and 
Marm-Whitley-Wilcox  rank sum test and confidence interval analysis were 
performed on velocities of monocytes on control or IL-4-activated HUVEC 
(Minitab statistical software, release 7, Minitab Inc., State College, PA). 
p  values 6  0.05 were considered significant. 
Results 
Elutriated Monocytes Maintain Expression 
of  L-Selectin and CD18 
To obtain monocytes without loss of L-selectin, we used the 
elutriation strategy  devised by Doherty and coworkers (14, 
15) that requires only a short (~20 min) elutriation protocol 
to obtain purified monocytes. Isolation of monocytes from 
peripheral blood mononuclear leukocytes by this protocol 
resulted in minimal alterations in cell surface L-selectin or 
CD18 expression as documented by indirect immunofluores- 
cence analysis (Fig.  1). Such monocytes were used in all ex- 
periments reported. 
IL-4 Treatment of  HUVEC Monolayers Induces 
VCAM-1 Surface Expression but Does Not Alter 
ICAM-1 or Induce E-Selectin Surface Expression 
Previous reports have shown that rhIL-4 selectively activated 
HUVEC to express VCAM-1  without altering  ICAM-1  ex- 
pression  or  inducing  E-selectin  expression  (49,  60).  We 
confirmed these findings  in our model system using surface 
immunofluorescence assays and found that VCAM-1 expres- 
sion was maximal after 24 h of treatment  (data not shown). 
Based on these observations,  subsequent experiments were 
performed using 24 h treatments  with IL-4. 
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Figure 1. Monocyte expression of L-selectin and CD18. Peripheral  ~/(T)-  (~ 
blood mononuclear leukocytes isolated on density gradients (Top, 
a and c) and elutriated monocytes (Bottom, b and d) were incubated  0  ~-~'-  ?~  I 
with mAb TS1/18 or LAM1-3 to assess the surface expression of 
CD11/CD18 and L-selectin, respectively, using indirect immunoflu- 
oreseence flow cytometric analysis (solid lines). The FITC fluores- 
cence intensity (four decade scale) of monocytes stained with an 
isotype-matched non-binding control (mAb K16/16 (4) IgGt) is in- 
dicated by a broken line. Data presented were essentially identical 
to that obtained in seven separate preparations. 
IL-4-activated Endothelium Supports 
Increased Peripheral Blood Monocyte Adhesion 
under Rotating Conditions 
Adhesion  of  peripheral  blood  monocyte  to  unactivated 
HUVEC monolayers was low under rotating conditions (75 
d- 46 monocytes/field, mean +  SD, N  =  13).  In contrast, 
IL-4  treatment  of human  HUVEC  monolayers  for  24  h 
promoted a sevenfold increase in monocyte adhesion to 527 
+  111  monocytes/field (N  =  12).  Adhesion studies  with 
HUVEC monolayers incubated for 24 h with varying con- 
centrations of IL-4 revealed a  dose-dependent increase in 
monocyte adhesion that was significantly increased at 0.1 ng 
IL-4/mi and reached a plateau at  10 ng IL-4/mi (data not 
shown). 
An 11.,-4 Inducible Endothelial Ligand for 
L-Selectin in Conjunction with VCAM-I Mediate 
Monocyte Adhesion under Rotation 
Increased adhesion of monocytes to IL-4-activated endo- 
thelium was detectable by 4 h, increased at 24 h, and was 
sustained for at least 48 h  (Fig. 2). When adhesion assays 
were performed with endothelium activated with IL-4 for 
various times in the presence of function blocking anti-L- 
selectin mAb (LAM1-3), adhesion was significantly reduced 
at each time point. In parallel, anti-VCAM-1 mAb (EU6) also 
significantly inhibited adhesion, and the combination of  anti- 
L-selectin and anti-VCAM-1 blocked essentially all cytokine- 
induced monocyte adhesion at each time point. These data 
indicate that an activation-dependent L-selectin ligand(s) is 
induced on the endothelial cell surface by 4 h and expression 
is sustained for up to 48 h. 
0  4  24  48 
TIME  (HOURS) 
Figure 2.  Kinetics  of endothelial  expression  of an  L-selectin 
ligand(s). Confluent HUVEC monolayers were treated for 0, 4, 24, 
or 48 h with rlL-4, washed four times and incubated with appropri- 
ate mAb as detailed in Materials and Methods. Monocyte suspen- 
sions were incubated with mAb on ice for 20 rain, and then added 
to HUVEC monolayers under rotating conditions. Adherent mono- 
cytes were enumerated as detailed in Materials and Methods. 
Using a panel of mAb that recognize spatially and func- 
tionally distinct epitopes on L-selectin (54), blocking studies 
were carried out to determine the epitopes on L-selectin in- 
volved in monocyte attachment to IL-4-activated HUVEC. 
Anti-LAMI-1, -3, -4, -6, and -7 mAb, which block lympho- 
cyte (56) binding to high endothelial venules (HEV), and 
lymphocyte and monocyte adhesion to TNF-activated en- 
dothelium (55), also inhibited monocyte attachment to IL-4- 
activated endothelium (46,  62, 75, 55, and 55 % inhibition, 
respectively), mAb that do not block lymphocyte and mono- 
cyte attachment to HEV or HUVEC (LAM1-5,  -10, -11) also 
failed  to  block  monocyte  attachment  to  IL-4-activated 
HUVEC. Thus, similar epitopes of L-selectin are involved 
in monocyte and lymphocyte adhesion to endothelium. 
IL-4-activated Endothelium Supports 
Monocyte Adhesion and Spreading under Defined 
Laminar Flow 
Monocyte-endothelial interactions were examined under de- 
fined flow in an in vitro model system (50). Monocyte adhe- 
sion to unactivated HUVEC monolayers declined as the wall 
shear stress increased, and few monocytes attached above 
0.8 dynes/era  2 (Fig. 3). In contrast, monocytes bound well 
to IL-4-activated endothelial monolayers at levels of wall 
shear stress up to 1.8 dynes/era2; however no adhesion oc- 
cuffed at 4.4  dynes/cm  2.  Based on these data,  all  subse- 
quent studies were carried out at 1.8 dynes/cm  2. 
Examination of monocyte-endothelial interactions revealed 
that a significant number of monocytes rolled on IL-4-acti- 
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Figure 3.  Monocyte  adhesion  to  endothelial  monolayers  under 
defined flow conditions.  Confluent IL-4-activated or -unactivated 
HUVEC  monolayers  were  prepared and  inserted  into  the  flow 
chamber, and monocytes were perfused through the chamber at var- 
ious flow rates (resulting in the estimated wall shear stresses indi- 
cated) as detailed in Materials and Methods.  Data are from three 
separate experiments. 
vated HUVEC monolayers and that these monocytes traveled 
at slower velocities than those few monocytes rolling on con- 
trol endothelial  monolayers (78  +  18  #m/s vs 205  +  53 
#m/s;  N  =  3,  p  ~<  0.001;  Table I).  Thus,  IL-4-activated 
HUVEC support increased numbers of monocytes that are 
interacting  with  the  endothelium,  and  thereby exhibit  re- 
duced rolling velocities that lead to dramatically increased 
monocyte adhesion. 
Visual examination of monoc~jte  interactions with the IL- 
4-activated endothelium  revealed  numerous  monocytes in 
contact with the apical surface of endothelial cells, some of 
which had become stably attached (arrested). The video im- 
ages in Fig. 4 depict the sequence of cellular events that leads 
to  monocyte transendothelial  migration  on  IL-4-activated 
endothelial  monolayers  under  defined  flow  at  1.8  dynes/ 
Table L  Monocyte Rolling  Velocities on 
Interleukin-4-activated Endothelium under Flow 
HUVEC treatments/mAb  Monocyte rolling velocities 
(#m/s) 
Unactivated, media  205  5:53 
IL-4-activated, media  78 5:  18" 
W6/32 (HLA-A,B complex)  83  5:  14, 
LAMI-3  (L-selectin)  303  5:699 
LAMI-14 (L-selectin)  79 5: 40* 
MAB 13 (CD29, flrintegrins)  109  5: 30* 
19H8 (~)  93  5:  19' 
El/6 (VCAM-1)  87 5: 20* 
TS 1/18 (CD18, fl2-integrins)  77 +  18, 
Monocyte rolling velocities were determined as  detailed in  Materials and 
Methods. 
* Monocyte velocities were significantly lower on IL-4-treated  HUVEC  vs 
control HUVEC (p ~  0.001). 
¢ mAb W6/32, LAMI-14, MABI3, El/6, and TSI/18 did not significantly 
alter monocyte rolling velocities as compared to media-treated IL-4-activated 
HUVEC. 
§ LAM1-3 significantly increased monocyte rolling velocities (p ~  0.001) as 
compared to treatments with media or non-function  blocking LAMl-14 mAb. 
Figure 4. Monocytes roll,  ar- 
rest, spread, and transmigrate 
across  1L-4-activated  endo- 
thelial  monolayers  under 
laminar flow. Monocytes were 
perfused  across  24  h  IL- 
4-activated HUVEC monolay- 
ers at 1.8 dynes/cm 2. Sequen- 
tial  video  frames  depicting 
monocyte rolling  (arrowhead 
and arrow, a-c), arrest (d, ar- 
rowhead),  spreading  (e,  ar- 
rowhead), and transendothe- 
lial migration  (f, arrowhead) 
were digitized. The appropri- 
ate areas of interest from each 
digitized  video  frame  were 
combined  using  commercial 
software to create the compos- 
ite image. This composite im- 
age shows the various  stages 
that occur between monocytes 
and  activated  endothelial 
monolayers  under  defined 
flow at  1.8  dynes/cm  2.  The 
images a-f were  taken from 
video tape 2,  2,  2,  18,  and 
33 s  apart  (,~1 min  elapsed 
time). 
cm  2. In Fig. 4 a, a rolling monocyte (arrowhead) traveling 
at 71 #m/s abruptly arrests (Fig. 4 b) and subsequently rolls 
slowly for •4  s (Fig. 4, b-d), before stably arresting again 
(Fig. 4 d); the cell then spreads (not shown), then migrates 
toward the endothelial intercellular junctions (Fig. 4  e, ar- 
rowhead) and transmigrates beneath the endothelial mono- 
layer (Fig. 4 f).  A  second monocyte (Fig. 4, a-c, arrows) 
roils slowly on the endothelial monolayer surface before re- 
leasing into the flow stream. In these studies, arrested mono- 
cytes either:  (a) released and resumed rolling interactions 
with the endothelium at 60-80 gm/s; (b) subsequently began 
slowly rolling (1-10 #m/s) on the apical surface; (c) remained 
adherent and retained their  round,  spherical morphology; 
(d) remained stationary and spread on the apical endothelial 
cell surface; or (e) spread on the apical surface of endothelial 
cells  and  migrated  to  intercellular  borders  before  trans- 
migrating. 
L-Selectin Facilitates Monocyte Adhesion 
Via cxd31-  VCAM-1 under Flow 
The contributions of both L-selectin- and VCAM-l-depen- 
dent adhesion pathways to monocyte attachment and rolling 
on IL-4-activated HUVEC  were evaluated at a  wall shear 
stress  of  1.8  dynes/cm  2.  In  agreement  with  the  data  ob- 
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control HUVEC monolayers, whereas adhesion to IL-4-acti- 
vated endothelium was increased *13-fold (Table ID. Anti- 
HLA-A,B complex mAb had no inhibitory effect on mono- 
cyte adhesion to IL-4-activated HUVEC monolayers. How- 
ever,  treatment of monocytes with function blocking mAb 
directed to L-selectin (LAM1-3) inhibited >90%  of mono- 
cyte adhesion, whereas LAMI-14, a isotype-matched mAb 
which recognizes an epitope in the short consensus repeat 
region of L-selectin that is not involved in adhesion (24, 56), 
did not inhibit adhesion. Function blocking mAb directed to 
VCAM-1 (EF6)blocked 97% ofmonocyte  adhesion. Control 
mAb Hu8/4, an isotype-matched mAb which recognizes an 
epitope on VCAM-1 that is not involved in adhesion to endo- 
thelium (58), had no inhibitory effect, mAb directed to ei- 
ther oL4B1 (CIM9d) or to flrintegrins (CD29), which inter- 
acts  with  VCAM-1, also  inhibited  >89%  of  monocyte 
adhesion. In contrast, mAb directed to fl2-integrins had no 
inhibitory effect on monocyte adhesion under flow. Thus, 
both L-selectin and ot~, but not fl2-integrins, participate in 
monocyte arrest on IL-4-activated endothelial monolayers 
under flow. 
The role of both L-selectin and VCAM-I-ot4fl~ adhesion 
pathways in monocyte rolling and arrest under flow could be 
easily distinguished both visually and by measuring rolling 
velocities of monocytes incubated with appropriate mAb. 
mAb directed to a,flt or VCAM-1 did not significantly al- 
ter  the  velocities of monocytes rolling on IL-4-activated 
HUVEC  (Table  I),  but did block arrest (Table  II).  Anti- 
L-selectin mAb (LAM1-3) significantly inhibited monocyte 
rolling and thereby,  inhibited >90%  of attachment. In the 
presence of mAb to either L-selectin or VCAM-I-ot~, few 
if any slow rolling (1-10/~m/s)  monocytes were observed. 
Taken together, the data suggest that L-selectin interacting 
with its inducible endothelial ligand allows monocytes to de- 
Table II.  Monoclonal Antibody Inhibition  of Monocyte 
Adhesion under Flow 
t"q 
Adherent  Inhibition of  E 
HUVEC treatments/mAb  (N)  monocytes/mm2  adhesion  E 
(%) 
Unactivated, media  7  53  +  82  -  .< 
IL-4 activated,  media  3  677  +  169  -  _J 
W6/32  (HLA-A,B complex)  6  821  ±  241  -  I 
I'... 
LAM1-3 (L-selectin)  4  134  4- 46*  89* 
LAMI-14 (L-selectin)  2  1273  +  156  0  o~ 
El/6  (VCAM-1)  3  77  4-  109"  97* 
Hu 8/4 (VCAM-1)  1  961  +  224  0  Z 
MAB  13  (CD29,  flrintegdns)  2  26  +  6*  100"  t.o 
19H8 (t~t)  2  141  +  91"  89*  t~ 
LId 
TS  1/18 (CD18,  fl2-integrins)  3  909  -1-  146  0  "1- 
t:3 
Confluent control or IL-4 activated HUVEC monolayers were washed four  "< 
times, incubated with various mAb for 30 rain at 37"C, and then inserted into 
the flow  chamber. Concomitantly, monocytes (12  x  106 in  1 ml perfusion 
media) were incubated with media alone or media containing various control 
or function blocking mAb for 20 min, diluted to  12 ml, and then perfused 
across the HUVEC monolayer. All studies were carried out at a wall shear 
stress  of  1.8  dynes/era:.  N  =  number of  separate  experiments.  Firmly 
adherent cells were  determined (40x  objective)  at  the end of 10  rain  of 
monocyte perfusion (rolling cells were not included). 
* Monocyte adhesion was  significantly inhibited  by  mAb  LAM1-3  (p 
0.0011),  E1/6 ~  0.0007),  MAB13 (p ~  0.0005),  and c~fl~ (p ~  0.015) as 
compared to control mAb W6/32 (anti-HLA-A,B). 
celerate to rolling velocities that facilitate the interaction of 
o~4fll with VCAM-1, which in turn, mediates arrest on the 
activated endothelial surface. 
The  ability of a4Bz-VCAM-1 pathway alone to  mediate 
stable attachment of monocytes under flow was examined 
using monolayers of L-cells stably expressing the seven do- 
main form of VCAM-1. By quantitative fluorescence im- 
munobinding assay, these L-cell transfectants uniformly ex- 
press  VCAM-1 at levels  comparable to that expressed by 
IL-4-activated endothelium and supported VCAM-1 depen- 
dent adhesion (see Materials and Methods). At 1.8 dynes/ 
cm:, monocytes did not roll on or attach to L-celI-VCAM-1 
monolayers. Moreover, no adhesion or rolling was observed 
at 0.8 dynes/cm  2 with either L-cell-VCAM-1 or untransfected 
L-cell monolayers. Thus,  ct4B~ interactions with VCAM-1 
stably expressed on murine L-cells was not sufficient to sup- 
port monocyte adhesion under flow in this system. 
U937-LAM1 but Not U937 Cells Roll and Attach 
to Activated Endothelium at 1.8 Dynes/cm 2 
To  further  investigate whether  rolling  of monocytes via 
L-selectin is necessary for adhesion in this system, we exam- 
ined the attachment of  monocyte-like U937 cells, which con- 
stitutively express o~43~ but not L-selectin, and U937-LAM1 
cells, which were stably transfected with the human cDNA 
of L-selectin and constitutively express both L-selectin and 
c~43m. L-selectin expression on U937-LAM1  cells was uni- 
formly high ('~15-fold  brighter than isotype-matched non- 
binding control mAb K16/16; average of two experiments) 
whereas expression on U937  cells was negative as deter- 
mined by flow cytometry. U937-LAM1  cell attachment to 
control HUVEC declined as the shear stress increased and 
essentially no adhesion occurred at 1.8 dynes/cm  2 (Fig. 5). 
In  contrast,  IL-4-activated endothelium supported  U937- 
LAM1 cell adhesion up to  1.8 dynes/cm  2.  The pattern of 
adhesion under various levels of flow for U937-LAM1 cells 
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Figure 5, U937-LAM1 cell adhesion to endothelial monolayers  un- 
der defined flow conditions. Confluent IL-4-activated or -unacti- 
vated HUVEC monolayers  were prepared and inserted into the flow 
chamber, and stably transfeo~ U937-LAM1 cells were perfused 
through the chamber at various flow rates as detailed in Materials 
and Methods. Data are from two separate experiments. 
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U937  cells  did  not  attach  to  control  or  IL-4-activated 
HUVEC at either 1.8 or 0.8 dynes/crn  2 (N =  3 experiments). 
These  data  imply that the  combination of L-selectin plus 
o~4~1 interacting with their respective endothelial ligands is 
necessary  and  sufficient  for rolling  and  arrest  under  flow 
conditions. 
Further  experiments  examined  U937-LAM1  rolling  and 
attachment to IL-4-activated endotheliurn in the presence of 
appropriate mAb. In three separate experiments,  the effects 
of function blocking mAb on U937-LAM1 cells were essen- 
tially the same as that for monocytes. Anti-L-selectin mAb 
caused a  significant increase in rolling velocities (LAM1-3, 
332  +  55/~m/s,  mean  +  SD, vs media control, 99  +  34 
#m/s; p  <  0.002)  and totally  inhibited  upregulated  U937- 
LAM1 adhesion as compared to media control (Table 111). 
Similarly, anti-CD29 and anti-VCAM-1 rnAb blocked all up- 
regulated  U937-LAM1  adhesion but had no significant ef- 
fects on U937-LAM1 rolling (velocities with anti-CD29, 112 
+  14  #m/s).  These  results  corroborate the  data  obtained 
with monocytes, and demonstrate that stable surface expres- 
sion of L-selectin in U937 cells  (c~+/31 and L-selectin posi- 
five) confers the ability to roll on, and stably bind to, IL-4- 
activated endothelium under flow. 
32-Integrins Mediate Monocyte Spreading but Not 
Rolling or Attachment under Flow 
Treatment of monocytes with function blocking anfi-CD18 
mAb (TS1/18) consistently had no effect on monocyte rolling 
velocities or attachment to IL-4-acfivated HUVEC (Tables 
I and II). However, anti-CD18 mAb did reduce the number 
of  adherent monocytes which spread or transmigrated across 
the endothelial cell monolayer. The video images in Fig. 6 
show the extent of  monocyte adhesion and spreading to IL-4- 
activated HUVEC in the presence of LAMI-14 (non-function 
blocking L-selectin),  anti-/~2-integrin  (TS1/18)  or anti-anti- 
a~l  (19H8) mAb (Fig.  6, a-c, respectively).  Many mono- 
cytes attached and spread (depicted by arrows) to activated 
endothelium treated with control LAMI-14 mAb (Fig.  6 a; 
26 5= 5 % of adherent monocytes were spread/transmigrated, 
N  =  124 monocytes counted in seven separate  fields with 
Table IlL  Monoclonal Antibody Inhibition  of U937-LAMI 
Adhesion under Flow 
Adherent 
HUVEC treatments/mAb  U937-l.aml/mm  2  Inhibition  of adhesion 
(%) 
Unactivated,  media  63  +  42  - 
630  +  99  IL-4-activated,  media  21  +  21  100" 
LAM1-3 (L-selectin)  63  +  44  100" 
El/6 (VCAM-1)  10 +  15  100" 
MABI3 (CD29) 
Confluent control or IL-4-activated HUVEC monolayers were prepared as 
detailed in Table I1. U937-LAMI (12  x  10  ~ in 1 ml pcrfusion media) were 
incubated with media alone  or media  containing  various  mAb, diluted to 12 ml, 
and then perfused across the HUVEC monolayer.  All studies were carried out 
at wall shear stress of 1.8 dynes/era  2. The data are representative of two 
separate experiments. Adherent cells were determined as in Table H, 
*  U937-LAMI cell adhesion was significantly inhibited (/7 ~ 0.03) by mAb 
LAM1-3, El/6,  and MABI3 as compared to rnedia-treale..d IL-4-activated 
HUVEC. 
Figure 6.  Anti-/~2 integrins  inhibit  spreading  of attached  mono- 
cytes but not rolling or attachment under flow. Various frames of 
video tape recordings of monocyte adhesion to endothelium under 
flow were digitized  and photographed. Monocytes were perfused 
across IL-4-activated endothelial  monolayers in the presence  of 
control non-blocking anti-L-selectin  mAb (LAMI-14) (a), function 
blocking mAb directed to 82-integrins  (TS  1/18) (b), or function 
blocking anti-a+flt  (19H8)  (c)  and the experiments  recorded on 
videotape using a  Nikon TMD  inverted  microscope and a 40x 
phase contrast objective. The tapes were replayed and selected por- 
tions of the video frames were digitized and photographed. Arrows 
indicate  spread/transmigrated  monocytes. 
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the presence  of function blocking anti-fl2-integrins  mAb, 
significantly  fewer  monocytes  spread  or  transmigrated 
across the endothelial monolayer (Fig. 6 b; 8  +  4%, N  = 
223 cells, 5 fields, p ~< 0.0008)  as compared to LAMI-14 or 
19H8 mAb). Overall, fl2-integrin mAb reduced spreading/ 
transmigration  by  69%.  In  contrast,  although  anti-a,B~ 
mAb greatly reduced monocyte attachment, this treatment 
did not reduce monocyte spreading (Fig. 6 c; 51  :i:  13%, N 
=  19 cells, 6 fields). 
Discussion 
To our knowledge this is  the first report to examine the 
cellular processes and molecular mechanisms of monocyte- 
endothelial adhesive interactions under defined flow con- 
ditions in vitro.  A  recent model of leukocyte-endothelial 
interactions has proposed that this process requires multiple, 
sequential steps (7).  The initial contact between the leuko- 
cyte and endothelial cell surface at normal levels  of blood 
flow is mediated primarily by selectins interacting with their 
carbohydrate ligands. This interaction appears to be revers- 
ible unless the second phase, leukocyte  activation, is initiated. 
Activation may occur by appropriate chemoattractants or ac- 
cessary molecules that trigger surface adhesion molecules to 
become "activated" (i.e., change their avidity for counter- 
receptors/ligands [53]). Once activated, these molecules can 
engage their endothefial counter-receptors, and thus, initiate 
phase three, firm adhesion (arrest). Using an in vitro flow 
chamber and function blocking mAb, we have extended this 
model in the present study and have identified, at the cellular 
and molecular level, the events necessary for monocyte ar- 
rest and transmigration across endothelium which has been 
selectively activated with IL-4 (and lacks E-selectin) (see 
Fig. 7). The data indicate that monocytes decelerate and roll 
on the activated endothelium via L-selectin interacting with 
its inducible ligand(s) (Phase I). This step is reversible. The 
next step involves monocyte ot4Bt interacting with VCAM-1 
(Phase II). It is not known if OuBrVCAMq  interaction re- 
quires  cell activation, although previous  studies have re- 
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Figure 7. Model of  monocyte  attachment to IL-4-activated  HUVEC 
monolayers  under flow. This figure shows  the four sequential events 
(Phases I-/V) that were observed during monocyte interactions 
with IL-4-activated endothelial monolayers at 1.8 dynes/cm  2. Our 
observations indicate that L-selectin mediates monocyte rolling (I) 
and also facilitates a,Brdependent  firm adhesion or arrest (II), 
and that fl2-integrins mediate spreading (III),  and in conjunction 
with CD31 (39), mediate monocyte  transendothelial  migration (/V) 
under flow. 
ported  that  VCAM-I-tx~  can  mediate  adhesion  at  4°C. 
These data imply that activation of monocyte a,fl~  may not 
be necessary (53, 55, 56) in this in vitro system. Once the 
otd~-VCAM-1 pathway is engaged, monocytes attach stably 
under flow conditions (Figs. 6 and 7). Adherent monocytes 
then spread on the apical surface of  the endothelium in a pro- 
cess that involves  fl:-integrins (Phase I~).  This step most 
likely requires activation (57) and presumably involves en- 
gagement of ICAM-1 and/or ICAM-2 on the endothelial sur- 
face. Once spread, monocytes migrate to intercellular junc- 
tions and diapedese between endothelial cells (Phase IV). 
Recent studies suggest this latter process is dependent, in 
part,  on homotypic interactions of PECAM-1  (CD31)  ex- 
pressed  on both leukocytes and endothelittm (39).  Taken 
together, these observations suggest a  more complex,  se- 
quential model for monocyte-endothelial interactions than 
previously appreciated. 
The evidence supporting this model of monocyte-endothe- 
lial interactions under flow is as follows.  First, consistent 
with previous studies (36, 49, 61), IL-4 treatment of  HUVEC 
monolayers induced VCAM-1 expression, but did not alter 
ICAM-1  expression and did not induce E-selectin expres- 
sion.  Second,  few  monocytes adhered  (<50  monocytes/ 
mm  2) to unactivated endotheliurn at wall shear stress levels 
i> 0.8 dynes/cm  2.  In contrast, IL-4 treatment of HUVEC 
monolayers induced a dramatic increase in monocyte adhe- 
sion at levels of wall shear stress up to 1.8 dynes/cm  e. The 
velocities of  monocytes were reduced on the activated mono- 
layers as compared to control HUVEC, and a significant frac- 
tion of  these monocytes were roiling. Third, functional block- 
ing mAb to  either L-selectin, VCAM-1, or ot,fl~ blocked 
monocyte adhesion  to  activated endothelium under  both 
non-static (rotation assay, 75 % inhibition) and defined flow 
(90%  inhibition at 1.8 dynes/cm  2) conditions. Blockade of 
L-selectin function by mAb LAM1-3 caused an increase in 
monocyte rolling velocities to levels that were not statistically 
different from that of monocytes flowing across unactivated 
endothelium. Few, if any, rolling monocytes were observed 
with LAM1-3 treatment, whereas control non-blocking LAM1- 
14 had no inhibitory effect on monocyte rolling or adhesion 
(Tables I and II). These data are consistent with previous re- 
ports using neutrophils that demonstrated that L-selectin is 
crucial for rolling in vivo (32, 62) and accumulation at sites 
of inflammation (26,  64).  In  contrast,  function blocking 
mAb directed to/~-integrins or VCAM-1 did not alter roll- 
ing velocities but instead increased the number of rolling 
cells. Fourth, a4fll appeared to be the principal/3~-integrin 
involved in stable adhesion under flow since an t~  specific 
mAb  (19H8)  was  nearly as  effective as  fl~-directed  mAb 
(MAB  13) in blocking adhesion. Since a4fl~-specific mAb 
blocked >90% of adhesion, it is unlikely that other c~-sub- 
units of/3~-integrins,  such as oe5 or c~6, are involved.  Fifth, 
as was demonstrated in experiments with the monocyte-like 
U937  and U937-LAM1  cell lines, both adhesion pathways 
are necessary for rolling and adhesion. U937 cells, which 
express ot4fl~ but not L-selectin (VLA4  ÷, L-sel-), do not roll 
on or attach to (<10 cells/ram  2) IL-4-activated endothelial 
monolayers  at  1.8  dynes/cm  2 (Fig.  5).  However,  U937- 
LAM1  cells,  which  express  both  L-selectin  and  VLA4 
(VLA4  ÷, L-sel÷), rolled on and stably adhered to IL-4-acti- 
vated endothelium at 1.8 dynes/cm:. The characteristics of 
U937-LAM1  cell adhesive interactions with the activated 
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cytes.  Function  blocking  mAb  specific  for  either  o~1, 
VCAM-1 or L-selectin, but not/32-integrins (CDll/CD18), 
blocked >95 % of adhesion. Finally, monocytes did not roll 
on or attach to murine L-ceil monolayers stably expressing 
VCAM-1 at levels comparable to IL-4-activated HUVEC, in- 
dicating that VCAM-l-~xd31 interactions alone are not suffi- 
cient to arrest monocytes at 1.8 dynes/cm  ~. 
This report provides the first clear indication that/3~- and 
/32-integrins have distinct functions in monocyte adhesive 
interactions with the vascular endothelium. Specifically, 13~- 
integrins functioned in stabilizing the initial attachment un- 
der flow (arrest),  whereas  /32-integrins were required for 
cell spreading and motility once the monocyte had stably 
bound to the apical surface of an endothelial cell. This is in 
contrast to neutrophils, which do not express c~/3t-integrins 
and which use/32-integrins to mediate firm attachment to 
endothelium (35,  51,  62).  It is  of interest that monocyte 
/32-integrins  are  not  used  for  arrest  to  IL-4-activated 
HUVEC,  because  /3z-integrins  can  clearly  mediate  this 
function for neutrophils.  It is unlikely that IL-4-activated 
HUVEC do not transmit appropriate signals for activation of 
/~2-integrins, since /32-integrins are  involved in spreading. 
Neutrophils  may use  distinct 132-integrins for  arrest  and 
spreading, thereby making up for the lack of/3~-integrins. 
Future studies examining monocyte interactions with TNF-oe- 
or  IL-1/3-activated  HUVEC  monolayers,  which  express 
elevated levels of E-selectin as well as ICAM-1 and VCAM-1, 
may provide additional insight into the molecular mecha- 
nisms of the differential function of/3~- and/32-integrins in 
monocyte arrest under flow. 
Recent reports have identified endothelial cell molecules 
from lymphoid tissues that may function as ligands for a chi- 
meric L-selectin molecule. Lasky et al. (28) have cloned a 
cDNA from a murine lymph node cDNA library that en- 
codes a serine/threonine-rich protein core, termed glyCAM-1 
(glycosylation-dependent  cell adhesion molecule), that func- 
tions as a ligand for L-selectin. Expression of  this ligand was 
constitutive and restricted to peripheral lymph node and 
mesenteric HEV endothelial cells in mice; glyCAM-1 ex- 
pression was not upregulated with an inflammatory stimu- 
lus. More recently this group has identified CD34, another 
mucin-like molecule, as a ligand for a L-selectin chimeric 
molecule (3). It will be important to determine the distribu- 
tion and expression of this molecule in various tissues (both 
lymphoid and non-lymphoid and at peripheral vascular beds 
at sites of inflammation) and to determine its role in L-selec- 
tin dependent monocyte as well as other leukocyte cell type 
rolling on  vascular endothelium.  In  addition,  Salmi and 
Jalkanen  (46)  reported  the  immunopurification of a  90- 
kD ligand, termed VAP-1, from tonsillar extracts that sup- 
ports lymphocyte adhesion. VAP-1 was absent from normal 
HUVEC and treatment with various cytokines (TNF-o~, IL- 
l/3  and LPS) for 4  or 24 h  did not induce expression of 
this molecule in cultured HUVEC.  Thus,  it appears  that 
the ligand on an activated peripheral vascular endothelium 
for  L-selectin is  distinct from VCAM-1,  E-selectin,  and 
ICAM-1,  and that it also is distinct from the constitutively 
expressed lymphocyte  homing receptor ligand expressed on 
HEV endothelial cells glyCAM-1 or other previously de- 
scribed molecules (28).  The results from our time-course 
study under rotation (Fig. 2) indicate that this endothelial 
ligand for L-selectin is induced by 4 h and remains elevated 
for at least 48 h. Previous studies have demonstrated that 
TNF-ct or IL-1/3 treatment of cultured HUVEC also induced 
an endothelial ligand(s) for L-selectin that contributes to 
lymphocyte, monocyte, and neutrophil adhesion (55, 56). At 
this time,  we have no direct evidence that the L-selectin 
ligand(s) induced by IL-4, IL-1, or TNF-ct are distinct, and 
the results from our mAb epitope mapping experiments and 
our previous studies (54, 55, 56) would suggest that similari- 
ties exist in the region of the L-selectin involved in interac- 
tions with the endothelial ligand for L-selectin. L-selectin in- 
teraction  with  its  endothelial  ligand(s)  is  an  important 
adhesion pathway that facilitates monocyte attachment to ac- 
tivated endothelium; molecular characte  "nzation of vascular 
endothelial ligand(s) will be an important goal for dissecting 
the role of monocyte emigration in such inflammatory re- 
sponses as transplant rejection, and in atherosclerosis. 
The data presented in Fig. 1 indicate that elutriated mono- 
cytes are not significantly activated during the isolation pro- 
tocol.  This is an important consideration in the study of 
monocyte-endothelial interactions. Using a modification of 
the protocol of Doberty et al.  (14,  15),  monocytes were 
elutriated in less than 20 rain and were consistently >--89% 
pure with very low neutrophil or lymphocyte contamination 
and essentially no platelet contamination. Previous studies 
have demonstrated that during neutrophil and monocyte acti- 
vation L-selectin is shed concomitant with a  2-5-fold in- 
crease in CD18 expression (18, 24, 26, 27, 51, 55, 57). Ex- 
pression of L-selectin and CD18  on elutriated monocytes 
were essentially identical to monocytes in the mononuclear 
fraction isolated by density gradient. The preparations of 
monocytes used  in  these  experiments  also  did  not bind 
significant levels of mAb 15/7, which recognizes an activa- 
tion epitope of o~  (Pizcueta, P., F. W. Luscinskas, and T. 
Yednock, manuscript in preparation).  Moreover, the basal 
adhesion of monocytes to unactivated endothelium under ro- 
tation or flow was consistently low, again suggesting that 
elutriated monocytes were not activated. 
At 1.8 dynes/cm  2, most monocytes in contact with the ac- 
tivated endothelium were rolling at ~80/~m/s, and some of 
these rolling monocytes had velocities in the range of 3-10 
#m/s (Fig. 4). This population of slowly rolling monocytes 
exhibited features similar to that previously described for 
neutrophils  interacting with activated endothelium under 
flow (51): transient adhesion to endothelium (<5 s) followed 
by release and resumption of rolling at '~3-10 ~m/s. That 
monocytes roll rather than slide or tumble under flow was 
clearly distinguished under a 40x  objective; the large nu- 
cleus rotated as the cell traveled across the surface of the 
endothelial monolayer. Another feature of monocyte-endo- 
thelial interactions under flow was that adherent monocytes 
locally altered the laminar flow profile. Initially, monocytes 
bound to endothelial cells in a random fashion, but once a 
monocyte bound, attachment of subsequent cells in the vicin- 
ity occurred preferentially  just downstream from the first cell 
rather than to areas with no attached cells. This pattern of 
adhesion may be due to flowing monocytes following local 
disturbances in the flow above or behind adherent cells and/ 
or because adherent cells protruded above the monolayer 
surface and therefore were in contact with a greater number 
of flowing monocytes. This alteration in laminar flow also 
has been observed with neutrophils interacting with immo- 
Luscinskas et al. Monocyte Adhesion to Endothelium under Flow  1425 bilized P-selectin (29).  Finally, the pattern of monocyte at- 
tachment under increasing levels of wall shear stress (Fig. 
3) indicates that between 1.8 and 4.4 dynes/cm  2, the proad- 
hesive attachment  forces generated by L-selectin interacting 
with its endothelial ligand(s) alone were unable to sustain 
monocyte  contact  with endothelium.  Although  the  pump 
used with the flow plate apparatus  was unable to produce 
flow rates intermediate between 1.8 and 4.4 dynes/cm  2, the 
data presented is sufficient to allow comparison to previous 
published results with neutrophils. Lawrence et al. (30) re- 
pored that neutrophil adhesion to unactivated  endothelium 
was negligible above 1.0 dynes/cm  2 whereas neutrophil ad- 
hesion to IL-1- or LPS-activated endothelium was sustained 
at 2.0 dynes/cm  2, but was negligible at 3.0 dynes/cm  2. These 
results thus are similar to the data shown in Fig. 3 for mono- 
cytes. 
Monocytes attached  and spread on the luminal surface of 
the IL-4-activated endothelium under flow, but few migrated 
underneath  the monolayer.  In contrast,  neutrophils readily 
transmigrated  across TNF-ot-activated  HUVEC monolayer 
under flow (51,  52).  In preliminary experiments using 6 h 
TNF-c~-activated  HUVEC,  monocytes do roll, attach,  and 
transmigrate  in large numbers under the endothelial mono- 
layer. This result suggests that the lack of emigration is not 
because monocytes are unable to migrate under flow in this 
system, but, rather that IL-4 does not induce sufficient levels 
of endothelial accessory molecules or other factors which 
are necessary for transmigration.  For example, Lo et al. (33) 
reported that E-selectin, which is induced by TNF-ot,  IL-1, 
and LPS but not IL-4, selectively activates neutrophil CDllb/ 
CD18 function and migration, processes which could facili- 
tate transmigration.  IL-4 also induces approximately one- 
third the level of VCAM-1 expression and MCP-1 production 
as compared to TNF-~ ([44] Ding, H., and E W. Luscinskas, 
unpublished observations). 
In  sununary,  using  IL-4-activated  HLrVEC  monolayers 
which selectively express VCAM-1 and an L-selectin ligand 
but not E-selectin, and appropriate  function blocking mAb, 
we have examined monocyte-endothelial interactions in an in 
vitro flow model.  We found that monocytes rolled on and 
stably  bound  to  IL-4-activated  endothelium  under  flow; 
L-selectin mediated monocyte rolling and facilitated c~4/3~- 
integrin-dependent arrest under flow. Subsequent monocyte 
spreading  required/32-  but not/3~-integrins.  These findings 
extend current models of leukocyte-endothelial recognition 
to reveal additional steps, mediated by specific adhesion re- 
ceptors, involved in the interactions of blood monocytes with 
endothelium under defined flow conditions. 
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